Author(s): Janmajoy Banerjee, Ranabir Chanda, Subhasis Samanta, Dipanjan Karati


DOI: 10.52711/2231-5713.2023.00024   

Address: Janmajoy Banerjee1, Ranabir Chanda2, Subhasis Samanta3, Dipanjan Karati4*
1Department of Pharmaceutical Technology, Gitanjali College of Pharmacy, Lohapur, West Bengal, India.
2Principal, Sana College of Pharmacy, Kodad, Telangana, India, 508206.
3Doctor, Binayak Multi-specialty Hospital, Sinthee, Kolkata, West Bengal, India, 700050.
4Department of Pharmaceutical Technology, Techno India University, Kolkata, West Bengal, India.
*Corresponding Author

Published In:   Volume - 13,      Issue - 2,     Year - 2023

ABSTRACT: Background: A novel human virus called coronavirus, SARS-CoV-2, or COVID-19, has become a pandemic disease. It was started last week of November 2019 in Wuhan, a city in China. It causes severe respiratory tract infections and other diseases. It is transmitted from human to human within incubation times between two to ten days. It is spread via droplets, contaminated hands, or surfaces. Recently research concluded the new SARS-Cov-2 coronavirus that causes the Covid-19 disease has a mutated gene that is found in the HIV virus. Plasmodium vivax and Plasmodium falciparum are two major types of the parasite which causes malaria in human. Main Body: More than 200 countries throughout the world have become suffered from malaria, and every year a large number of people die by the cause of malaria. We observed that there was no significant effect of coronavirus, SARS-CoV-2, or COVID-19 on malaria-affected countries. As per the recommendation given by World Health Organization, Artemisinin and its derivatives like Dihydroartemisinin, Artemether, Arteether, and Artesunate are used to kill parasites at an early phase of their development, quickly decreasing their numbers. Among all derivatives, Artesunate has the activity against HIV virus, and HIV virus has some structural similarity with coronavirus SARS-Cov-2 as both are RNA-based virus. There is a possibility for using Artesunate in malaria-infected countries; the coronavirus SARS-Cov-2 is unable to show a significant impact on malaria-affected countries. Conclusion: Zinc can increase the immunity against viral infections, especially on those viruses that cause infection in the respiratory tract. In our hypothesis, we suggest the use of Artesunate along with Zinc as a prophylaxis agent against coronavirus, COVID-19.

Cite this article:
Janmajoy Banerjee, Ranabir Chanda, Subhasis Samanta, Dipanjan Karati. Control of COVID-19 using Artesunate, an Antimalarial First Line Drug: A Review. Asian Journal of Pharmacy and Technology. 2023; 13(2):130-4. doi: 10.52711/2231-5713.2023.00024

Janmajoy Banerjee, Ranabir Chanda, Subhasis Samanta, Dipanjan Karati. Control of COVID-19 using Artesunate, an Antimalarial First Line Drug: A Review. Asian Journal of Pharmacy and Technology. 2023; 13(2):130-4. doi: 10.52711/2231-5713.2023.00024   Available on:

1.    Guy JS, Breslin JJ, Breuhaus B, Vivrette S, Smith LG. (2000) Characterization of a Coronavirus Isolated from a Diarrheic Foal. Journal of Clinical Microbiology. 2000; 38(12):4523–4526.
2.    Jain RS, Jain TG, Ishikar SK. Impact of Covid-19 on Changing Habits and Health Issues of the Public. Asian Journal of Management. 2020; 11(4):524-528.
3.    Vijayashree L, Srinivasa S. Covid 19 and Stress among Students. Asian Journal of Management. 2021; 12(4):477-2.
4.    Solanki R, Singh K. Covid 19 home confinement effects on consumer's food consumption and eating habits. Asian Journal of Management. 2021; 12(4):487-0.
5.    Pandurangan H. Middle East Respiratory Syndrome (MERS) a Threat to Asian Countries. Asian J. Nursing Education and Research. 2018; 8(3):375-378.
6.    Hoek LVD, Pyrc K, Jebbink MF, Oost WV, Berkhout RJM, Wolthers KC, Dillen PMEW, Kaandorp J, Spaargaren J, Berkhout B. Identification of a new human coronavirus., Nature Medicine. 2004; 10(4):368-373.
7.    Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research. 2020; 7 (11): 2-10.
8. virus-has-mutated-gene-similar-to-hiv-and-is-1,000-times-more-potent.
9.    Dewangan V, Sahu R, Satapathy T, Roy A. The Exploring of Current Development status and the unusual Symptoms of Coronavirus Pandemic (Covid-19). Res. J. Pharmacology and Pharmacodynamics. 2020; (4):172-176.
10.    WHO. Novel Coronavirus-Japan (ex-China). 2020. don/17-january-2020-novel-coronavirus-japan-ex-china/en/. Accessed 1 Feb 2020.
11. Novel 2019 Coronavirus Genome 2020. t/novel-2019-coronavirus-genome/319. Accessed 1 Feb 2020.
12.    Fehr AR, Channapannavar R, Perlman S. Middle East respiratory syndrome (MERS): Emergence of a pathogenic human Coronavirus., Annu Rev Med. 2017; 14(68):387–399.
13.    Karati D, Kumar D, Sathiyanarayanan L and Mahadik KR. A Concise Review on Origin, Nature, Characteristic Features, and Plausible Drugs for Treatment against Covid-19, Open Access Journal of Pharmaceutical Research. 2020; 4(4):000220.
14.    Karati D. Immunity and Spiritual Care in Prevention of Covid 19, Journal of Corona Virus. 2021; 1(4),
15.    Naresh BV. A Review of the 2019 Novel Coronavirus (COVID-19) Pandemic. Asian J. Pharm. Res. 2020; 10(3):233-238.
16.    Rokade M, Khandagale P. Coronavirus Disease: A Review of a New Threat to Public Health. Asian J. Pharm. Res. 2020;10(3):241-244.
17.    Gupta R. The Management of Coronavius Pandemic 2019-2020. Asian J. Pharm. Res. 2020; 10(4):327-330.
18.    Muthyala N. A Mini Review Medicinal plants with Antiviral properties against SARS-CoV-2. Research Journal of Pharmacognosy and Phytochemistry. 2021; 13(3):158-0.
20.    Vishnu KN, Uppala PK, Vangoori Y, Gudhanti SNKR. A Review on Covid 19 Pandemic and its Global Effects. Asian Journal of Pharmaceutical Research. 2021; 11(4):242-6.
21.    Talele SG, Ahire ED, Surana KR, Sonawane VN, Talele GS. Corona Virus Disease (COVID-19): A past and Present Prospective. Asian Journal of Pharmaceutical Research. 2022; 12(1):45-3.
22.    Chavhan AB, Jadhav PS, Shelke S. COVID 19: Outbreak, Structure and Current therapeutic strategies. Asian J. Pharm. Tech. 2021; 11(1):76-83.
24.    Garner P. Artesunate combinations for treatment of malaria: meta-analysis., The Lancet. 2004; 363,
25.    Gopalakrishnan AM, Kumar N. Antimalarial Action of Artesunate Involves DNA Damage Mediated by Reactive Oxygen Species., Antimicrobial Agents and Chemotherapy. 2015; 59(1):317-325.
26.    Pinheiro LCS, Feitosa LM, Silveira FFD, Boechat N. Current Antimalarial Therapies and Advances in the Development of Semi-Synthetic Artemisinin Derivatives., Anais da Academia Brasileira de 2018; Ciências 90 (1 Suppl. 2): 1251-1271.
27.    Newton P, Mongkol YS, Isavadharm PT, Pukrittayakamee S, Navaratnam V, Bates I, White N. Antimalarial Bioavailability and Disposition of Artesunate in Acute Falciparum Malaria., Antimicrobial Agents and Chemotherapy. 2000; 44(4):972–977.
28.    Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJG, Marschall M. The Antiviral Activities of Artemisinin and Artesunate. 2008; CID 47:804-811.
29. malaria-free-by-who.
31.    Management of Severe Malaria: A Practical handbook., 2nd Edition, 2000; WHO, WHO – CDS.
32.    Morris CA, Duparc S, Fuhrer IB, Jung D, Shin CS, Fleckenstein L. Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration., Malaria Journal. 2011; 10(263):2-17.
34.    Batty KT, Thu LA, Davis TE, Ilett K, Mai TX, Hung NC, Tien NP, Powell SM, Thien HV, Binh TQ, Kim NV. A Pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria., British Journal of Clinical Pharmacology. 1998; 45: 123-129.
35.    Pooja S, Hanekom Damian H (2020) Does zinc improve symptoms of viral upper respiratory tract infection? Evidence-Based Practice.,
36. virus-has-mutated-gene-similar-to-hiv-and-is-1,000-times-more-potent-4.

Recomonded Articles:

Author(s): Safa Mohammed Sadiq, Amtul Kareem, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5713.2017.00002.2         Access: Open Access Read More

Author(s): Sindhu. T. J, Arathi. K. N, Akhilesh K. J, Anju. Jose, Binsiya K. P, Blessy Thomas, Elizabeth Wilson

DOI: 10.5958/2231-5713.2020.00012.4         Access: Open Access Read More

Author(s): G. Baskar, J. Chandhuru, K. Sheraz Fahad, A.S. Praveen

DOI:         Access: Open Access Read More

Author(s): Vavilala Prateesh Kumar, Ch. Madhu, Kavya Mannem, V.S. Asha, A. Sambasiva Rao, M. Sravan Prasad

DOI:         Access: Open Access Read More

Author(s): S.K. Purohit, R. Solanki, R. Soni, V. Mathur

DOI:         Access: Open Access Read More

Author(s): Indu Rathore

DOI: 10.5958/2231-5713.2017.00014.9         Access: Open Access Read More

Author(s): Ch. Madhu, J. Swapna, R. Sneha Spandana, I. Niharika, K. Rohith Raj, B. Kalyan, M. Rajarajeshwari, T. Prathyusha

DOI:         Access: Open Access Read More

Author(s): Saylee Madkholkar, Vijay Jagtap

DOI: 10.52711/2231-5713.2022.00039         Access: Closed Access Read More

Author(s): Archana B. Chavhan, Pavan S. Jadhav, Satish Shelke

DOI: 10.5958/2231-5713.2021.00013.1         Access: Open Access Read More

Author(s): Saira Sehar, Mohsin Sher Ali Khan, Amiza, Touqir Hussain, M. Zahid, Moazina Mobeen, Imran Raza, Minnatullah

DOI: 10.52711/2231-5713.2022.00035         Access: Closed Access Read More

Author(s): Subhashis Debnath, Jaya Saha

DOI: 10.52711/2231-5713.2022.00011         Access: Closed Access Read More

Author(s): Ketaki Shinde, Sonam Bendre, Niraj Kale, Suhit Gilda

DOI: 10.52711/2231-5713.2022.00042         Access: Closed Access Read More

Asian Journal of Pharmacy and Technology (AJPTech.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5713 

Recent Articles